Dear Valued Broker Partner,

We'd like to inform you of an important update regarding our ongoing efforts to manage the rising costs associated with pharmaceutical benefits.

As part of our Prescription Drug Oversight strategy, our health plan is reinforcing a focus on prescribing cost-effective generic medications wherever clinically appropriate.

This initiative is designed to maintain high standards of care while also helping to keep premiums more affordable and minimize unnecessary healthcare spending.

Generic medications are FDA-approved, safe, and effective alternatives to brand-name drugs, offering the same therapeutic benefits at a significantly lower cost. By law, generic drugs must be the same as an already marketed brand-name drug in terms of dosage form, safety, strength, route of administration, quality, performance characteristics, and intended use. They work in the same way and provide the same clinical outcome as their brand-name counterparts, making them a smart and affordable choice for patients and employers.

This approach supports our shared goal of cost containment while ensuring that members continue to receive the best possible care.

We truly appreciate your continued partnership and support as we work together to deliver value-driven healthcare options.

Warm regards,



SIMNSA Health Plan